Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health

Corundum Systems Biology Inc.,(CSB), a group company of Corundum Innovation Co., Ltd. and a Japan-based company that brings together microbiome research and business creation, has newly invested in Sequential Skin Ltd.,a microbiome start-up focused on creating a world with healthier microbiomes. The investment is CSB’s first direct investment in the field of skin-microbiome.

Learn more by visiting

About Corundum Innovation

Corundum Innovation Co., Ltd., and Corundum Ventures Ltd. (Hereafter Corundum) provide venture capital (VC) investment and consulting services to investors for both financial and strategic returns. Corundum provides flexible services to COIF’s investors for new business development in various phases with our expertise in science, technology, business development, corporate management, finance and consulting, as well as our strong network with top Israeli VC and the valuable information we can access through fund activities. Corundum’s support includes information gathering, negotiation for partnership, direct investment, market development, HR development, and fund formation.


Corundum Innovation Co., Ltd.